Search results

• Active

  A Phase 3, Randomized, Open-Label Study To Evaluate the Efficacy and Safety of Eflornithine with Lomustine Compared to Lomustine Alone in Patients with Anaplastic Astrocytoma That Progress/Recur After Irradiation and Adjuvant Temozolomide Chemotherapy

  Villano, PhD, J. (PI) & Thind, R. (CoI)

  Orbus Therapeutics Incorporated

  9/1/16 → 1/5/26

  Project: Research project

• Finished

  A Phase 3, Randomized, Controlled, Double-Arm, Open-Label, Multi-center Study of VB-111 Combined with Bevacizumab vs. Bevacizumab Monotherapy in Patients with Recurrent Glioblastoma

  Villano, PhD, J. (PI) & Thind, R. (CoI)

  PPD Investigator Services LLC

  5/13/16 → 5/12/18

  Project: Research project

• 15-LUN-100-HR: A Phase III, Open-label, Randomized Study of Atezolizumab (MPDL3280A, ANTI-PD-L1 Antibody) in Combination With Carboplatin or Cisplatin + Pemetrexed In Patients Who Are Chemotherapy-Naive and Have Stage IV Non-Squamous

  Arnold, S. (PI), Anthony, L. (CoI), Thind, R. (CoI), Villano, PhD, J. (CoI) & Hosein, P. (Former CoI)

  Genentech Inc

  4/29/16 → 10/20/20

  Project: Research project

• 15-NEURO-06-NLG (NLG-2102) A Phase 1/2 Study of the Combination of Indoximod + Temozolomide for Adult Patients with Temozolomide-Refractory Primary Malignant Brain Tumors

  Villano, PhD, J. (PI), St Clair, W. (CoI) & Thind, R. (CoI)

  NewLink Genetics

  3/4/16 → 11/14/19

  Project: Research project

• 15-28-HN-28-GT (GT-201): A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of the Effects of Intravenous GC4419 on the Incidence and Duration of Severe Oral Mucositis (OM) in Patients Receiving Post-Operative or Definitive Therapy

  Kudrimoti, M. (PI), Arnold, S. (CoI), St Clair, W. (CoI) & Thind, R. (CoI)

  Galera Therapeutics Incorporated

  2/24/16 → 2/23/18

  Project: Research project

• An Open-label, Single-Arm Phase 2 Study Evaluating the Efficacy, Safety and Pharmacokinetics of Rovalpituzumab Tesirine (SC16LD6.5) for Third-Line and Later Treatment of Subjects with Relapsed or Refractory Delta-Like Protein

  Arnold, S. (PI), Anthony, L. (CoI), Thind, R. (CoI), Villano, PhD, J. (CoI) & Hosein, P. (Former CoI)

  Stemcentrx Incorporated

  2/11/16 → 8/14/19

  Project: Research project

• IRX-2 2015A: A Randomized Phase 2 Trial of Neoadjuvant and Adjuvant Therapy with the IRX-2 Regimen in Patients with Newly Diagnosed Stage III or IV Squamous Cell Carcinoma of the Oral Cavity

  Valentino, J. (PI), Aouad, R. (CoI), Arnold, S. (CoI), Escott, E. (CoI), Gal, T. (CoI), Kudrimoti, M. (CoI), Thind, R. (CoI), Kenady, D. (Former PI) & Curtis, W. (Former CoI)

  PPD Development Inc

  1/25/16 → 7/26/23

  Project: Research project

• 15-LUN-97-G1T (G1T-28-02) G1T28 in Patients with Extensive-Stage SCLC receiving Etoposide+Carboplatin Chemotherapy

  Arnold, S. (PI), Anthony, L. (CoI), Thind, R. (CoI), Villano, PhD, J. (CoI) & Hosein, P. (Former CoI)

  G1 Therapeutics Incorporated

  1/20/16 → 7/19/18

  Project: Research project

• 15-HN-27-AZ (D4193C00002) MEDI4736 Monotherapy and MEDI4736 plus Tremelimumab Vs Standard of Care in SCCHN

  Arnold, S. (PI), Anthony, L. (CoI), Thind, R. (CoI) & Hosein, P. (Former CoI)

  Pharmaceutical Research Associates

  12/14/15 → 10/27/19

  Project: Research project

• 15-GBM-10-IT (ICT-107-301) A Phase III study of ICT-107 plus maintenance temozolomide (TMZ) in newly diagnosed GBM

  Villano, PhD, J. (PI), St Clair, W. (CoI) & Thind, R. (CoI)

  ImmunoCellular Therapeutics Limited

  12/3/15 → 5/2/18

  Project: Research project